Conditions: Heparin-induced Thrombocytopenia Type II
Keywords: Argatroban heparin induced thrombocytopenia (HIT) direct thrombin inhibitor (DTI)
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 20
Healthy volunteers: no

Brief summary:
The purpose of this study is to collect data on the clinical management of Argatroban in patients with suspected or confirmed heparin-induced thrombocytopenia Type II, with or without ongoing thrombosis who require parenteral antithrombotic therapy

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: argatroban
Intervention descriptions: intervention 1: None

Protocol document: